Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health : Caremark launches new efforts to tackle health disparities

09/15/2021 | 08:42am EDT

Company expands existing initiatives to address systemic inequities with long-term, collaborative focus on community-based programs for patients with serious chronic illnesses

WOONSOCKET, R.I. - CVS Caremark, the Pharmacy Benefit Manager (PBM) of CVS Health (NYSE: CVS), today announced an expansion of its efforts to decrease health disparities among patients with certain conditions including sickle cell, HIV, and cardiovascular disease by collaborating with local partners and utilizing its unique enterprise assets. The company is increasing its investments in programs that address barriers to care and developing additional initiatives to help disadvantaged populations and alleviate inequities in the U.S. health care system.

CVS Caremark's approach will focus on the following principles:

  • A four-pillar programmatic approach: 1) awareness and educational resources, 2) testing and screening, 3) access to health services, and 4) treatment optimization interventions

  • Collaborate with community-based organizations and patient advocacy groups to deliver care where the people are

  • Utilize enterprise assets including health care services available in CVS HealthHUB® locations and legacy corporate social responsibility programs such as Project Health where appropriate

  • Measure and share results on an ongoing basis for continuous learning

'We serve one in three Americans and have the information and insights that help us understand not just where the disparities in care are occurring but, most importantly, why,' said Alan Lotvin M.D., President of CVS Caremark and Executive Vice President, CVS Health. 'We know systemic inequities have existed for decades and can't be solved by one person, community or company. We believe we have the obligation and the ability to partner with others to change the health trajectory for many patients who have been impacted by them for too long.'

CVS Caremark is working with its clients to create health equity strategies for PBM members with certain conditions that disproportionately affect patients of color. The company will also use its broad reach and collaborate with community partners to determine the best ways to influence systemic change for those who've struggled with disease for many years and for newly diagnosed members.

Among its goals are doubling the number of patients on hydroxyurea for people living with sickle cell disease (SCD), improving adherence among those already on the drug, and significantly increasing trait testing. SCD is an incredibly painful disease that primarily affects communities of color and left untreated can lead to life-threatening complications. Hydroxyurea, a low-cost medication, can help patients better manage their condition by reversing the sickling of blood cells. In some areas the number of people with SCD has doubled because many people who carry the trait that can lead to developing the condition, are not aware of it. Increasing trait testing starting with greater awareness and education, can help consumers make more informed decisions. CVS Caremark plans to work with national and community organizations to understand the needs of local communities and develop programs to increase awareness and access.

The company is also adding to existing initiatives to increase awareness about HIV testing and prevention for CVS Caremark members, particularly among communities of color by sharing educational resources with those at risk, and helping patients initiate preventive therapy when appropriate. These efforts are incremental to the company's ongoing participation in the Ready, Set, PrEP initiative by the U.S. Department of Health and Human Services aimed at eliminating 90 percent of new HIV infections by 2030 and helping end the AIDS epidemic. While a multitude of social, economic and demographic factors impact HIV transmission rates throughout the U.S., low-income individuals, minorities (especially African Americans and Hispanics/Latinos) and LGBTQ+ populations are among the most vulnerable to HIV.

For cardiovascular disease, CVS Caremark aims to increase initiation of medication therapy amongst people facing health disparities and help ensure those already on treatment are on an optimized dosage to reach their target blood pressure and staying adherent to their regimen.

In all disease areas, the company will work with local community organizations and advocacy groups to ensure those facing health inequities have access to the resources and care they need.

About CVS Health

CVS Health is the leading health solutions company, delivering care in ways no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and our nearly 300,000 dedicated colleagues - including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health - whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system - and their personal health care - by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.

Media contact

Riddhi Trivedi-St Clair


CVS Health Corporation published this content on 15 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 September 2021 12:41:01 UTC.

ę Publicnow 2021
08:31aMore than 3 out of 4 Aetna Medicare Advantage members in 4.5 Star-rated plans or higher..
10/25Large employer group launches pharmacy benefit management business
10/25CVS HEALTH : Healthier Happens Together
10/22Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
10/22CVS HEALTH : Pharmacies Start Offering Moderna COVID-19 Booster Shots
10/22CVS HEALTH : Announces Availability of Moderna Booster to Eligible Populations
10/22CVS Health Corporation Announces Availability of Moderna Booster to Eligible Population..
10/21CVS HEALTH CORPORATION : Ex-dividend day for
10/19REINVENTING HEALTH CARE : The Aetna Connected Plan with CVS Health™ is helping deliv..
10/18CVS Health Names Joneigh S. Khaldun as Chief Health Equity Officer
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 284 B - -
Net income 2021 8 470 M - -
Net Debt 2021 48 981 M - -
P/E ratio 2021 13,7x
Yield 2021 2,27%
Capitalization 116 B 116 B -
EV / Sales 2021 0,58x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,6%
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 87,68 $
Average target price 97,05 $
Spread / Average Target 10,7%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President